Alcon bought Aerie Pharmaceuticals Aerie Pharmaceuticals from 11/22/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Alcon completed its acquisition of Aerie Pharmaceuticals for $770 million, or 15.25 per share.

Aerie Pharmaceuticals

Review

Source:

{source} pictogram

investor.alcon.com

Vladimir Petenev

News editor

Write your comment first

News feed

Yakovlev reported for 2023 by RAS

2/9/24 IRKT

Kamaz will develop hydrogen technologies in partnership with AFK Sistema

2/9/24 KMAZ

Sistema and Kamaz will develop hydrogen technologies

2/9/24 AFKS

Aeroflot's passenger turnover in January increased by 20.9%

2/9/24 AFLT

Tinkoff may create its own pension fund

2/9/24 T

Bank of Russia registered a split of Mosgorlombard shares

2/9/24 MGKL

Sberbank reported for January 2024 by RAS

2/9/24 SBER

Unit of Sinara Bank bought 3.6% of Softline

2/9/24 SOFL

Kristall will open the IPO book on February 12

2/9/24 KLVZ

Trading in TCS Group receipts suspended on February 16

2/8/24 T